CAMBRIDGE, Mass., July 11 /PRNewswire/ -- Gene Network Sciences (GNS) today announced that Zach Pitluk, Ph.D., has joined the company as vice president of business development. In this newly created role, he is responsible for driving commercial opportunities and strategic partnerships for GNS.
Pitluk joins GNS from Definiens, AG, the leading provider of enterprise image intelligence solutions, where he served as the North America life sciences business manager. Pitluk previously spent five years at Cellomics, a Fischer Biosciences business unit that provides complete systems for high content screening and analysis. During his tenure as national sales manager, the company's revenue increased 50 percent year-over-year. Prior to Cellomics, he held sales positions at Clontech Labs, Bristol-Myers Squibb and ISCO, Inc.
After graduating from Yale University with a Ph.D. in molecular biophysics and biochemistry, Pitluk spent six years at Yale as an NIH post-doctoral fellow and research faculty.
"Zach's proven success in managing top-10 pharma accounts and selling platform software is a direct match for our needs," said Colin Hill, CEO of Gene Network Sciences. "In addition, his strong scientific and research background gives him a real depth of knowledge about the GNS modeling software and how it can be used to help our customers accelerate their drug development efforts."
About Gene Network Sciences
Founded in 2000, Gene Network Sciences (www.gnsbiotech.com) is a privately held biosimulation company with offices in Cambridge, Massachusetts, and Ithaca, New York. GNS creates cell and organ-level computer models able to simulate the clinical performance of drugs and drug candidates. By predicting how and why specific compounds impact human biology and specific sub-populations, GNS technology increases clinical trial success rates and helps bring better drugs to market faster.
Gene Network SciencesCONTACT: Debbie Pfeifer of Gene Network Sciences, +1-206-282-5098, ordebbie@gnsbiotech.com
Web site: http://gnsbiotech.com//
